Nymox Pharmaceutical Corp (NASDAQ:NYMX)

0.6275
Delayed Data
As of Mar 27
 +0.0375 / +6.36%
Today’s Change
0.33
Today|||52-Week Range
5.76
+56.87%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close0.59
Today’s open0.60
Day’s range0.60 - 0.67
Volume74,371
Average volume (3 months)378,547
Market cap$22.5M
Dividend yield--
Data as of 3:48pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+39.13%
Earnings growth (this year)-14.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+9.32%
P/E ratioNM
Price/Sales61.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PRPHProPhase Labs Inc-0.01-0.75%
CLRBCellectar Bioscience...+0.02+0.63%
CDXICardax Inc0.000.00%
RCPIRock Creek Pharmaceu...-0.00-0.98%
Data as of 3:59pm ET, 03/27/2015

Financials

Last reporting dateMarch 23, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$3.4M
Annual profit (last year)-$4.9M
Net profit margin-146.13%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account